Open Access Open Access  Restricted Access Subscription or Fee Access

A Review on T POXX (TECOVIRIMAT)—A New Bioweapon Against Small Pox

M. Manasa Rekha

Abstract


As an author in the present review, I have provided all the available information regarding T POXX (TECOVIRIMAT)—a new bioweapon against small pox—like its synonym, history of discovery and approval, chemical structure, pharmacology, adverse drug reactions, drug interactions, safety concerns, contraindications, warnings/cautions, preclinical and clinical trial information and all other information after thoroughly searching in all the available resources. I hope this can be helpful to all the healthcare professionals and students to understand, grasp easily and recall quickly.

 

Keywords: POXX (TECOVIRIMAT), bioweapon, pharmacology, adverse drug reactions, drug interactions

Cite this Article

Rekha MM. A Review on T POXX (TECOVIRIMAT)—A New Bioweapon Against Small Pox. Research & Reviews: Journal of Medicine. 2018; 8(2): 9–11p.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Research & Reviews: Journal of Medicine